What is ZVSA's current stock price?

ZVSA (ZyVersa Therapeutics, Inc.) is currently trading at $0.18 with a market cap of $1.5M.

What sector is ZyVersa Therapeutics, Inc. in?

ZyVersa Therapeutics, Inc. (ZVSA) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

ZVSA ZyVersa Therapeutics, Inc.

Healthcare

$0.18+0.00%ClosedMarket Cap: $1.5M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-0.10

P/S

0.00

EV/EBITDA

-36.93

DCF Value

$0.02

FCF Yield

-284192.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

27.4%

ROA

-244.7%

ROIC

-16.5%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-1.79B	$—
Q4 null	$0.00	$-678.6K	$—
FY null	$0.00	$-24.95B	$—
Q3 null	$0.00	$-19.8M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

Cashmere Karen A.officer: Chief Commercial Officer

SellWed Jul 16

Wolfe Peterofficer: Chief Financial Officer

SellTue Jul 15

SAPIRSTEIN JAMESdirector

SellTue Jul 15

Park Min-Chuldirector

SellTue Jul 15

Guzman Pablo A.officer: Chief Medical Officer

SellTue Jul 15

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

0.79

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.

Peers

CDT